Please assess the completion status of the following clinical trial:

Trial Title: Optimisation of Hybrid Fittings for Cochlear Implant Recipients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult (≥18 years of age)~2. Post-operative residual hearing in the implanted ear (defined as having an unaided threshold better than or equal to 80 dB HL at the 500 Hz frequency).~3. Implanted with the CI500 or CI24RE-series cochlear implants~4. User of the commercially available Nucleus 6 sound processor~5. User of the ACE strategy~6. Native speaker in the language used to assess speech perception performance~7. Willingness to participate in and to comply with all requirements of the protocol~Exclusion Criteria:~1. Additional handicaps that would prevent participation in evaluations~2. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and investigational device

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cochlear Implant Recipients (Type: EXPERIMENTAL): Newly implanted cochlear implant recipients with post-implantation acoustic hearing.

Based on this trial design, predict the completion outcome and termination type (if applicable).